Schumacher, D.; Curaj, A.; Staudt, M.; Cordes, F.; Dumitraşcu, A.R.; Rolles, B.; Beckers, C.; Soppert, J.; Rusu, M.; Simsekyilmaz, S.;
et al. Phosphatidylserine Supplementation as a Novel Strategy for Reducing Myocardial Infarct Size and Preventing Adverse Left Ventricular Remodeling. Int. J. Mol. Sci. 2021, 22, 4401.
https://doi.org/10.3390/ijms22094401
AMA Style
Schumacher D, Curaj A, Staudt M, Cordes F, Dumitraşcu AR, Rolles B, Beckers C, Soppert J, Rusu M, Simsekyilmaz S,
et al. Phosphatidylserine Supplementation as a Novel Strategy for Reducing Myocardial Infarct Size and Preventing Adverse Left Ventricular Remodeling. International Journal of Molecular Sciences. 2021; 22(9):4401.
https://doi.org/10.3390/ijms22094401
Chicago/Turabian Style
Schumacher, David, Adelina Curaj, Mareike Staudt, Franziska Cordes, Andreea R. Dumitraşcu, Benjamin Rolles, Christian Beckers, Josefin Soppert, Mihaela Rusu, Sakine Simsekyilmaz,
and et al. 2021. "Phosphatidylserine Supplementation as a Novel Strategy for Reducing Myocardial Infarct Size and Preventing Adverse Left Ventricular Remodeling" International Journal of Molecular Sciences 22, no. 9: 4401.
https://doi.org/10.3390/ijms22094401
APA Style
Schumacher, D., Curaj, A., Staudt, M., Cordes, F., Dumitraşcu, A. R., Rolles, B., Beckers, C., Soppert, J., Rusu, M., Simsekyilmaz, S., Kneizeh, K., Ramachandra, C. J. A., Hausenloy, D. J., & Liehn, E. A.
(2021). Phosphatidylserine Supplementation as a Novel Strategy for Reducing Myocardial Infarct Size and Preventing Adverse Left Ventricular Remodeling. International Journal of Molecular Sciences, 22(9), 4401.
https://doi.org/10.3390/ijms22094401
